Scarica l'app Stockscreener
0.206
16.47%
-0.0332
Precedente Chiudi:
$0.2392
Aprire:
$0.2234
Volume 24 ore:
4.50M
Relative Volume:
0.42
Capitalizzazione di mercato:
$7.43M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-32.52%
1M Prestazione:
-39.67%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.1159
$0.23
Intervallo di 1 settimana:
$0.1159
$0.40
Portata 52W:
$0.1159
$2.22
Profusa Inc Stock (PFSA) Company Profile
Nome
Profusa Inc
Settore
Industria
Telefono
212-494-9022
Indirizzo
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Confronta PFSA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.206 | 9.99M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
122.72 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.28 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.13 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.14 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
80.44 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Profusa Inc Borsa (PFSA) Ultime notizie
Profusa outlines revenue plan, targets EU commercial launch of Lumee in early Q2 2026 - MSN
Profusa outlines EU launch of tissue oxygen monitoring in 2026 By Investing.com - Investing.com South Africa
Profusa outlines EU launch of tissue oxygen monitoring in 2026 - Investing.com
Profusa Unveils Strategic Plan for Revenue Growth - TipRanks
Profusa, Inc. Outlines Path to $250 Million Revenue by 2030 - TradingView
Profusa (PFSA) furnishes press release and investor presentation | PFSA SEC FilingForm 8-K - Stock Titan
Profusa (NASDAQ: PFSA) plans EU Lumee launch, targets up to $250M in revenue by 2030 - Stock Titan
Profusa (PFSA) Stock Skyrockets 36% on Milestone News – Can This Biotech Sensor Play Rebound? - ts2.tech
Why Profusa (PFSA) Stock Soared 36% After Hours? - Benzinga
Profusa, Inc.Common Stock (Nasdaq:PFSA) Stock Quote | User | malvern-online.com - FinancialContent
Profusa completes manufacturing milestones ahead of 2026 product launch - Investing.com
Profusa completes manufacturing milestones ahead of 2026 product launch By Investing.com - Investing.com Nigeria
Profusa IncOn track to provide inventory in Q1 2026 - MarketScreener
Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026 - GlobeNewswire
Profusa Invests $1 Million in Digital Treasury Assets - MSN
Profusa expands European footprint for Lumee Oxygen platform By Investing.com - Investing.com Australia
Profusa expands European footprint for Lumee Oxygen platform - Investing.com
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe - The Manila Times
Profusa expands sales footprint with new distributor for Lumee Oxygen platform in Europe - MarketScreener
Profusa Unveils Strategic Focus in Investor Update - TipRanks
Profusa, Inc. Expands Distribution of Lumee Oxygen Platform Across Major European Markets - Quiver Quantitative
Profusa Expands Sales Footprint with New Distributor for Lumee?? Oxygen Platform in Europe - MarketScreener
~35% EU Population Covered — Profusa Partners with Angiopro to Commercialize Lumee in Europe - Stock Titan
Profusa files prospectus relates to resale of up to 42.6 mln shares - MarketScreener
Profusa injects additional USD 1M into digital treasury assets - Medical Buyer
Profusa makes second $1 million bitcoin investment to hedge risks By Investing.com - ng.investing.com
Profusa invests additional $1 million in digital treasury assets - MSN
Profusa, Inc. announced that it has received $1 million in funding - MarketScreener
Profusa invests additional $1 million in bitcoin treasury assets By Investing.com - Investing.com
Profusa, Inc. Announces $1 Million Investment in Digital Treasury Assets to Support Biochemical Monitoring Technology - Quiver Quantitative
Second $1M Investment: Profusa Expands Bitcoin Digital Treasury Strategy; Ascent Funds $2M Tranche - Stock Titan
French vascular surgeon adopts Profusa’s oxygen monitoring tech By Investing.com - Investing.com Nigeria
French vascular surgeon adopts Profusa’s oxygen monitoring tech - Investing.com India
Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base - The Manila Times
8% of French CLTI Cases: Profusa's Lumee Technology Gains Major Adoption from Leading Surgeon Network - Stock Titan
Profusa’s Risky Vision for High-Tech Medical Sensors - Finimize
Profusa Restructures Securities Agreement for Flexibility - MSN
Profusa Faces Nasdaq Listing Compliance Challenges - MSN
Profusa receives Nasdaq notices for minimum value and bid price compliance - Investing.com
Profusa Approves $100 Million Equity Line of Credit - MSN
This Penny Stock Is Surging on an Nvidia Boost. Should You Buy Shares Now or Stay Far Away? - Barchart.com
Profusa Inc Azioni (PFSA) Dati Finanziari
Non sono disponibili dati finanziari per Profusa Inc (PFSA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
0.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):